Alerts will be sent to your verified email
Verify Email
LINKPH
|
Link Pharma Chem
|
Parmax Pharma
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.59 % | -1068.03 % | 10.99 % |
|
5yr average Equity Multiplier
|
1.99 | 29.23 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 1.05 | 0.25 |
|
5yr Avg Net Profit Margin
|
-0.06 % | -11.29 % | 77.44 % |
|
Price to Book
|
0.99 | 0.0 | 1.63 |
|
P/E
|
0.0 | 0.0 | 56.7 |
|
5yr Avg Cash Conversion Cycle
|
82.44 Days | -92.25 Days | 63.13 Days |
|
Inventory Days
|
64.96 Days | 69.37 Days | 54.75 Days |
|
Days Receivable
|
72.97 Days | 20.01 Days | 11.98 Days |
|
Days Payable
|
84.21 Days | 296.94 Days | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
2.35 | -0.77 | 820.35 |
|
5yr Avg ROCE
|
5.35 % | -14.3 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
3.76 % | 2.43 % | -130.11 % |
|
5 yr average Debt to Equity
|
0.49 | 10.96 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | -26.08 % |
|
5yr Average Return on Assets
|
0.6 % | -9.05 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.49 % | 30.8 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 1.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Link Pharma Chem
|
Parmax Pharma
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|